Researchers have developed an injectable reactive oxygen species-responsive nanoscaffold combined with mesenchymal stem cell-derived nanovesicles, designated RNS + NVs, for the treatment of spinal cord injury. In preclinical evaluations, the scaffold effectively scavenged and degraded reactive oxygen species while enabling the responsive release of nanovesicles to address severe inflammatory reactions and oxidative stress that exacerbate degenerative progression.
Although extracellular vesicles derived from mesenchymal stem cells are recognized for their capacity to alleviate inflammation following spinal cord injury, their natural yield is limited. To overcome this production constraint, researchers generated nanovesicles from mesenchymal stem cells using physical extrusion, obtaining substantially higher yields while preserving therapeutic activity.
In laboratory cell cultures, the extruded nanovesicles suppressed pro-inflammatory shifts and reduced the secretion of interleukin-6 and tumor necrosis factor-alpha from lipopolysaccharide-stimulated BV2 cells, matching the anti-inflammatory efficacy of natural extracellular vesicles. Furthermore, the nanovesicles demonstrated a more pronounced antioxidative effect than extracellular vesicles by mitigating oxidative stress damage in hydrogen peroxide-exposed PC12 cells.
In experimental spinal cord injury models, cellular uptake of the extruded nanovesicles was predominantly mediated by microglia and neurons. The combined RNS + NVs system exhibited synergistic actions by modulating the hostile local microenvironment during the acute post-injury phase.
By simultaneously controlling oxidative damage and acute neuroinflammation, the nanoscaffold and nanovesicle platform created a favorable setting for tissue healing, long-term locomotion recovery, and the alleviation of neuropathic pain, demonstrating strong potential as an antioxidant and anti-inflammatory intervention for spinal cord injury.
The study focuses directly on the dual pathophysiological barriers that characterize spinal cord injury: the surge in reactive oxygen species and the accompanying severe inflammatory reactions, both of which accelerate degenerative tissue breakdown. While conventional therapeutic exploration has utilized extracellular vesicles originating from mesenchymal stem cells to temper post-injury inflammation, low production yields have historically restricted their broader deployment. To resolve this limitation, the authors implemented physical extrusion of mesenchymal stem cells. This mechanical method yielded nanovesicles in quantities significantly higher than those achieved with naturally harvested extracellular vesicles, establishing an efficient manufacturing alternative while maintaining vital therapeutic capabilities.
The engineered nanovesicles were systematically integrated into a reactive oxygen species-responsive hydrogel nanoscaffold to create the combined RNS + NVs delivery system. In this formulation, the scaffold serves an active dual role rather than functioning as a passive carrier. It directly scavenges and degrades local reactive oxygen species, and this chemical scavenging process simultaneously triggers the responsive release of the encapsulated nanovesicles. By coupling biomaterial degradation directly to oxidative stress levels, the platform ensures that the therapeutic nanovesicles are discharged in response to the hostile microenvironmental conditions that drive spinal cord pathology.
In vitro cellular investigations detailed in the research demonstrated specific cellular responses across distinct neural cell models. In lipopolysaccharide-stimulated BV2 microglial cells, the extruded nanovesicles successfully suppressed pro-inflammatory alterations and decreased the secretion of interleukin-6 and tumor necrosis factor-alpha, achieving an anti-inflammatory efficacy comparable to that of natural mesenchymal stem cell extracellular vesicles. In oxidative stress assays utilizing hydrogen peroxide-treated PC12 neuronal cells, the nanovesicles provided a more pronounced antioxidative protective effect than standard extracellular vesicles, significantly attenuating cell damage caused by oxidative exposure.
Within experimental spinal cord injury models, cellular tracking revealed that the therapeutic uptake of extruded nanovesicles was predominantly carried out by microglia and neurons. The combination of the responsive scaffold and extruded nanovesicles operated synergistically to alter the damaging in vivo microenvironment during the critical acute post-injury phase. This modulation subdued acute neuroinflammation and oxidative damage, establishing favorable conditions for endogenous tissue healing, significant long-term locomotor recovery, and the alleviation of neuropathic pain in the evaluated animal models.
Published in BMC Biotechnology as accepted, peer-reviewed research, these findings define the baseline therapeutic potential of the RNS + NVs biomaterial platform under controlled laboratory conditions. The reported outcomes reflect observations derived strictly from cultured cell lines and preclinical animal injury models. Because human physiological responses to acute spinal cord trauma involve complex systemic factors not fully captured in experimental models, further translational evaluations remain necessary to determine whether these antioxidant, anti-inflammatory, and neuroprotective effects can be replicated in clinical therapeutic settings.
Subject of Research: Injectable ROS-responsive hydrogel delivering mesenchymal stem cell nanovesicles for spinal cord injury
Article Title: Regenerative therapy using MSCs-derived reinforced extracellular vesicles incorporated into ROS-responsive injectable hydrogel for the treatment of spinal cord injury
Article References: Guan, J., Chen, X., Cheng, J., Lu, Y., & Chen, X. (2026). Regenerative therapy using MSCs-derived reinforced extracellular vesicles incorporated into ROS-responsive injectable hydrogel for the treatment of spinal cord injury. BMC Biotechnology. https://doi.org/10.1186/s12896-026-01206-1
Image Credits: AI Generated
DOI: 10.1186/s12896-026-01206-1
Keywords: spinal cord injury, mesenchymal stem cells, nanovesicles, extracellular vesicles, hydrogel, reactive oxygen species, neuroinflammation, tissue healing, Regenerative, therapy, MSCs-derived, reinforced
News Source: Cassandra Pierce. (November 7, 2026). Injectable Hydrogel Delivering Stem Cell Nanovesicles Aids Spinal Cord Injury Models. Scienmag.



